Sector portfolio · VC firm · South Korea
Aju IB Investment's Biotech portfolio
Aju IB Investment has backed 12 Biotech startups in rounds we track, $1.2B between them, shown by the stage each has reached. The best-funded is Kymera Therapeutics.
Aju IB Investment's whole portfolioAju IB Investment's profile
Funding by segment
- Series C and later$1.0B4
- Series B$60M3
- Stage not reported$72M3
- Series A$16M2
Where they are based
- South Korea8$261M
- United States4$919M
South Korea
United StatesFounded
Total raised
- Under $1M0
- $1M to $10M1
- $10M to $50M8
- $50M to $250M2
- $250M to $1B1
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
12 of 12 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- South Korea8
- United States4
Startups by country, 2 countries in all.
Segment by segment
Series C and later
4 startups · $1.0B raised
Kymera TherapeuticsKymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.United States$799M
GI InnovationGI Innovation is a global leader of microbiome drug development.South Korea$143M
Clearside BiomedicalClearside BioMedical is an ophthalmic company that specializes in the research, development, and commercialization of therapeutic products.United States$72M
Kanaph TherapeuticsKanaph Therapeutics is a leading biotech in oncology, auto-immune, and eye diseases with large molecules and small molecules.South Korea$18M
Series B
3 startups · $60M raised
iN TherapeuticsiN Therapeutics is a spin-off biotech, from local leading pharmaceutical company, Daewoong Pharmaceuticals, with a new drug discovSouth Korea$22M
CaremediCaremedi is a wearable drug pump and healthcare company.South Korea$20M
ImmunoBiomeImmunoBiome is a biotech company developing microbiome therapeutics to treat incurable diseases like autoimmune diseases.South Korea$18M
Stage not reported
3 startups · $72M raised
Trefoil TherapeuticsTrefoil is a biotechnology company that brings forward novel engineered FGF-1 compounds to treat endothelial cell mediated diseases.United States$33M
GencurixGencurix develops various diagnostic products to support precision medicine.South Korea$24M- EENCellENCell is a biotech company that develops and manufactures biopharmaceuticals.United States$15M
Series A
2 startups · $16M raised
GenKOre(주)진코어(GenKOre)는 초소형 유전자가위 기술 기반의 독자적 유전자 편집 플랫폼인 ‘TaRGET 시스템’을 개발한 생명과학 연구기업입니다.South Korea$12M
Mxt BiotechMxT Biotech is a biotechnology company based in Seoul, South Korea, founded in 2021.South Korea$3.9M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Aju IB Investment as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Aju IB Investment?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.